3 min read

EverHint – EMA10 × Price × MACD Signals for Jan 23, 2026 – Consumer Cyclical Leads with 2 Setups

6 signals. Consumer Cyclical leads (2). 3 with insider selling. price range $17-$309. RSI 55-81. sectors: Consumer Cyclical (2), Healthcare (2), Technology (1). full analyst coverage, earnings data, 50.0% have news.

What This Signal Is (Quick)

This is an experimental strategy that combines two bullish signals occurring on the same day:

  1. Price crosses above EMA10 from below

    • Yesterday: price_prev <= ema10_prev
    • Today: price > ema10
    • Indicates price breaking above short-term trend
  2. MACD Line crosses above Signal Line from below

    • Yesterday: macd_line_prev <= macd_signal_prev
    • Today: macd_line > macd_signal
    • Confirms bullish momentum shift

Double Confirmation: Both crossovers must happen simultaneously on the signal date, providing higher-quality setups with stronger conviction.

Key Characteristics:

  • Buy signals only - This strategy generates only bullish signals (no sell signals)
  • Fewer but higher quality - Dual confirmation means 5-20 signals per day vs. 20-40 for single-indicator strategies
  • Fast response - EMA10 catches early momentum shifts
  • Momentum context - MACD adds underlying momentum confirmation
  • Swing trading focus - Ideal for 1-4 week holding periods

Key Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line

  • Sell: Price < EMA10 AND MACD line crosses below signal line

  • Minimum ADV: $40M (liquidity filter)

  • Earnings buffer: 7 days pre/post earnings

  • Fresh signal: All conditions met on today's close

Holding Period: 1-3 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by RSI (lower RSI = more oversold for buy signals)


📊 EMA10 × Price × MACD Signals (6 Total)

Ranked by rsi14:

Rank Ticker Company Sector Last ($) RSI14 Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 LLYVK Liberty Media Corporat... Communication Services 86.13 55.4 34 $3.60 7.9
2 LIF Life360, Inc. Technology 68.10 55.9 $-24.4M 34 $0.85 5.3
3 MCD McDonald's Corporation Consumer Cyclical 309.25 59.6 $-8.3M 17 $17.07 220.7
4 VRDN Viridian Therapeutics,... Healthcare 32.93 62.7 34 $3.46 2.7
5 SW Smurfit WestRock plc Consumer Cyclical 43.80 66.8 19 $4.42 22.9
6 MOVE Movano Inc. Healthcare 16.74 80.7 $-188K 74 $-14.50 0.0

Field Notes

Sector concentration: Consumer Cyclical (2), Healthcare (2), Technology (1)

Insider selling: MOVE (Movano Inc., $-188K), LIF (Life360, Inc., $-24.4M), MCD (McDonald's Corporation, $-8.3M)

Data coverage: 50.0% insider, 16.7% congressional (1 recent/90d), 100.0% earnings, 100.0% analyst, 50.0% news


Congressional Activity

LLYVK (Liberty Media Corporation - Ser) ⚪ Neutral (90d)


Recent Headlines

LIF (Life360, Inc.)

  • Why Life360 Stock Soared Today (source)
  • Overlooked Stock: LIF 20% Rally on Boosted Guidance (source)
  • Life360 To Report Record Q4 2025 Operational Performance (source)

MCD (McDonald's Corporation)

  • Market Today: Intel tumbles, TikTok JV, gas spikes, Netflix--WBD (source)
  • Worried About a Market Crash in 2026? Buy These 3 Stocks (source)
  • How McDonald's Returned $79 Billion To Shareholders (source)
  • Jeff Bezos Denies Advising Gen Z To Flip Burgers Or Slog It At Real World Jobs Like Palantir, But Elon Musk Says Trump 'Worked' At McDonalds (source)
  • I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. (source)
  • McDonald's bets big on hot honey and protein to bring in customers (source)

MOVE (Movano Inc.)

  • Why Is Movano Stock Gaining Today? (source)
  • Nvidia GPU Deal Sends This Stock Soaring Over 114% After-Hours: Here's What Happened (source)
  • Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads (source)

Market Context

The market exhibits mild mixed performance with the S&P 500 up 0.11% and Nasdaq advancing 0.26%, while the Dow Jones dips 0.34%. This divergence points to selective risk appetite favoring growth-oriented areas amid a broadly stable trend. For an EMA10 price MACD strategy, which relies on short-term momentum crossovers, these conditions support potential signal reliability in upward-biased segments, though the Dow's pullback signals caution in value-heavy areas, risking false positives on intraday reversals.

VIX at 16.09, rising 2.61%, reflects moderately elevated volatility that could amplify intraday swings, challenging the sensitivity of EMA10 and MACD to noise. In this environment, signals may experience heightened whipsaw risk during choppy sessions, particularly as volatility edges higher without spiking to extreme levels. Traders should prioritize confirmation from broader index momentum to filter noise.

With Consumer Cyclical as the top sector amid six total signals, sector rotation appears tilted toward economically sensitive areas, aligning with Nasdaq's relative strength and hinting at improving risk sentiment. This setup bolsters EMA10 MACD signals in cyclicals, where momentum could build on modest upside, but divergent index moves warrant tight risk management to navigate potential rotation shifts.


⚠️ Extended Non-Trading Period Alert

Important: The next 2 days (Saturday, January 24 through Sunday, January 25) are non-trading days (weekend/holiday).

What this means:

  • Markets will not reopen until Monday, January 26
  • News and events occurring over this extended non-trading period may significantly influence market sentiment
  • Monitor news flow closely during this period
  • Be prepared for potential gaps or increased volatility when markets reopen
  • Earnings announcements, geopolitical events, or major news during this period can lead to significant price movements at the open
  • Consider adjusting position sizes or using protective stops given the extended gap risk

Sharing Call-to-Action

💡 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/